Concord Wealth Partners’s 2seventy bio TSVT Stock Holding History
Bought
Maintained
Sold
Other funds holding TSVT
KCM
MAP
NM
BBA
CC
Concord Wealth Partners's TSVT Position: Q3 2024 in Review
Concord Wealth Partners sold out of 2seventy bio (TSVT) in Q3 2024, closing a stake of 2 shares — an estimated $8 sold.
Concord Wealth Partners first reported a position in TSVT in Q2 2024 and held it in 1 quarter. The position peaked at $8 in Q2 2024. 115 funds tracked by Wall St. Rank hold TSVT as of Q3 2024.
- Concord Wealth Partners reported no remaining 2seventy bio position as of Q3 2024 after selling out during the quarter.
- Concord Wealth Partners sold 2 2seventy bio shares in Q3 2024, an estimated $8.
- Concord Wealth Partners first reported a position in 2seventy bio in Q2 2024 and held it in 1 quarter.
- Concord Wealth Partners's 2seventy bio position peaked at $8 in Q2 2024.
- 115 funds tracked by Wall St. Rank held 2seventy bio as of Q3 2024.
Based on Concord Wealth Partners's 13F filing for Q3 2024, filed 24 Oct 2024.